According to a recent analysis by Emergen Research, the Global Water Soluble Drugs Market size was valued at USD XX in 2019 and is forecast to exceed USD XX Billion, at a CAGR of X% through 2027. The market growth is driven by the increased focus of pharmaceutical companies to formulate water-soluble drugs to get the desired pharmacological response in patients.
Water-soluble drugs are observing high demand as they offer high bioavailability and higher efficacy due to the generation of desired pharmacological responses in a body. These drugs are also processed efficiently in the body. Water solubility is a critical parameter while formulating a drug as it has a huge influence on the pharmacodynamics and pharmacokinetics of the drug. The solubility of a particular drug also affects its efficacy and bioavailability.
Read more @ https://www.emergenresearch.com/industry-report/water-soluble-drugs-market
Key Highlights From Report-
- Based on route of administration, the oral segment is forecast to make significant revenue contributions to the water-soluble drugs market share over the forecast period. Oral intake of the drug is the most convenient and commonly opted for mode of drug administration. Cost-effectiveness, patient compliances, and ease of administration are the key factors propelling segmental growth.
- In the regional landscape, North America led the water-soluble drugs market with the largest revenue share in 2019 and is expected to gain major traction through 2027. In the U.S., more than 40% of the oral drugs sold are poorly soluble in water, which is prompting pharmaceutical companies to actively participate in extensive R&D activities. This, in turn, will boost regional industry growth in the coming years.
- The Asia Pacific region is projected to showcase considerable growth over the analysis period on account of the focus on the development of advanced healthcare infrastructure expansion of the pharmaceutical and biotechnology sectors, along with a rapid surge in drug R&D activities in the region.
- Key players operating in the global water-soluble drugs market are Cipla, Merck & Co., Pfizer, Inc., Thermo Fisher Scientific, AstraZeneca, Novartis, Sanofi, Johnson and Johnson, GlaxoSmithKline, F. Hoffman-La Roche, Ltd., and Biogen, Inc., among others.
